| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F |
| Revenues: |
| Manufacturing Services | | | | 20.4 | 15.9 | | 48.5 |
| Laboratory Services | | | | | | | 253.5 |
| Other | | | | 386.8 | 318.2 | | |
| Total revenues | 674.3 | 578.1 | 499.9 | 407.2 | 334.1 | 270.0 | 253.5 |
| Revenue growth [+] | 16.6% | 15.6% | 22.8% | 21.9% | 23.7% | 6.5% | |
| Manufacturing Services | | | | 28.3% | | | |
| Cost of goods sold | 422.5 | 366.5 | 316.7 | 250.7 | 206.5 | 161.6 | 157.1 |
| Gross profit | 251.7 | 211.6 | 183.2 | 156.4 | 127.6 | 108.4 | 96.3 |
| Gross margin | 37.3% | 36.6% | 36.7% | 38.4% | 38.2% | 40.1% | 38.0% |
| Selling, general and administrative [+] | 23.4 | 16.2 | 29.8 | 21.7 | 10.5 | 23.0 | 56.8 |
| Sales and marketing | 0.7 | 0.7 | 15.3 | 10.3 | 0.1 | 7.4 | 7.4 |
| General and administrative | 22.7 | 15.5 | 14.4 | 11.5 | 10.4 | 15.6 | 49.4 |
| Research and development | 21.2 | 11.0 | 8.1 | 5.4 | 0.4 | | |
| Other operating expenses | 103.4 | 79.1 | 52.5 | 45.5 | 45.2 | 33.3 | |
| EBITDA [+] | 150.1 | 150.0 | 134.5 | 117.8 | 100.7 | 76.1 | 70.6 |
| EBITDA growth | 0.1% | 11.5% | 14.2% | 17.0% | 32.3% | 7.8% | |
| EBITDA margin | 22.3% | 25.9% | 26.9% | 28.9% | 30.1% | 28.2% | 27.9% |
| Depreciation | 45.2 | 43.8 | 39.2 | 31.9 | 25.9 | 20.4 | 31.0 |
| EBITA | 104.9 | 106.1 | 95.3 | 85.9 | 74.8 | 55.7 | 39.6 |
| EBITA margin | 15.6% | 18.4% | 19.1% | 21.1% | 22.4% | 20.6% | 15.6% |
| Amortization of intangibles | 1.2 | 0.9 | 2.5 | 2.1 | 3.3 | 3.6 | |
| EBIT [+] | 103.7 | 105.2 | 92.8 | 83.8 | 71.5 | 52.1 | 39.6 |
| EBIT growth | -1.4% | 13.4% | 10.8% | 17.2% | 37.2% | 31.7% | |
| EBIT margin | 15.4% | 18.2% | 18.6% | 20.6% | 21.4% | 19.3% | 15.6% |
| Non-recurring items [+] | | | 3.4 | | | | 60.5 |
| Asset impairment | | | 3.4 | | | | 60.5 |
| Interest income, net [+] | -0.6 | -0.4 | -1.0 | 5.6 | 1.3 | -0.8 | 0.9 |
| Interest expense | 0.6 | 0.4 | 1.0 | 0.4 | 0.3 | 0.8 | 1.4 |
| Interest income | 0.0 | 0.0 | 0.0 | 6.1 | 1.6 | 0.0 | 2.3 |
| Other income (expense), net [+] | 9.0 | 9.7 | -2.6 | -8.4 | 18.0 | 1.5 | 1.0 |
| Gain (loss) on investments | 12.7 | -4.0 | -0.6 | | | | |
| Change in value of contingent liability | | | 3.4 | | | | |
| Other | -9.0 | 13.9 | 4.9 | 2.7 | 26.3 | 5.3 | -1.0 |
| Pre-tax income | 112.2 | 114.6 | 85.8 | 81.0 | 90.8 | 52.9 | -19.0 |
| Income taxes | -24.5 | -23.5 | -0.8 | -16.6 | 0.0 | -0.4 | -4.0 |
| Tax rate | | | | | 0.0% | | 21.2% |
| Earnings from continuing ops | 112.2 | 114.6 | 86.6 | 81.0 | 90.8 | 53.4 | -15.0 |
| Earnings from discontinued ops | | | | | | -0.6 | -49.3 |
| Net income | 112.2 | 114.6 | 86.6 | 81.0 | 90.8 | 52.9 | -64.2 |
| Net margin | 16.6% | 19.8% | 17.3% | 19.9% | 27.2% | 19.6% | -25.3% |
| |
| Basic EPS [+] | $0.20 | $0.20 | $0.15 | $0.14 | $0.16 | $0.10 | ($0.03) |
| Growth | -1.5% | 32.6% | 6.7% | -12.5% | 66.2% | -435.2% | |
| Diluted EPS [+] | $0.19 | $0.20 | $0.15 | $0.13 | $0.15 | $0.09 | ($0.03) |
| Growth | -1.2% | 32.4% | 10.8% | -11.7% | 67.6% | -409.4% | |
| |
| Shares outstanding (basic) [+] | 563.8 | 567.3 | 568.4 | 567.1 | 556.3 | 543.9 | 510.2 |
| Growth | -0.6% | -0.2% | 0.2% | 1.9% | 2.3% | 6.6% | |
| Shares outstanding (diluted) [+] | 576.6 | 582.0 | 582.4 | 603.5 | 597.5 | 589.2 | 510.2 |
| Growth | -0.9% | -0.1% | -3.5% | 1.0% | 1.4% | 15.5% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |